Literature DB >> 13863315

Development of a technic for isolated perfusion of the liver.

R K AUSMAN.   

Abstract

Keywords:  LIVER; PERFUSION

Mesh：

Year:  1961        PMID： 13863315

Source DB:  PubMed          Journal:  N Y State J Med        ISSN： 0028-7628


× No keyword cloud information.
  10 in total

1.  In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.

Authors:  Heidi Colville; Ryan Dzadony; Rebecca Kemp; Stephen Stewart; Herbert J Zeh; David L Bartlett; Julianne Holleran; Kevin Schombert; Juliann E Kosovec; Merrill J Egorin; Jan H Beumer
Journal:  J Extra Corpor Technol       Date:  2010-03

2.  [A new method for isolated regional perfusion of the liver in vivo. Experimental studies (author's transl)].

Authors:  F Ghussen; K Nagel; W Isselhard; G Marx; A Wellart; E W Müller
Journal:  Langenbecks Arch Chir       Date:  1982

Review 3.  Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.

Authors:  Shuang Cai; Taryn R Bagby; M Laird Forrest
Journal:  Ther Deliv       Date:  2011-11

4.  True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function.

Authors:  Pierluigi Pilati; Simone Mocellin; Carlo R Rossi; Carlo Ori; Federico Innocente; Romano Scalerta; Mauro Ceccherini; Pier Paolo Da Pian; Donato Nitti; Mario Lise
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

Review 5.  Isolated hepatic perfusion for patients with liver metastases.

Authors:  Srinevas K Reddy; Susan B Kesmodel; H Richard Alexander
Journal:  Ther Adv Med Oncol       Date:  2014-07       Impact factor: 8.168

6.  Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.

Authors:  Elizabeth D Feldman; Peter C Wu; Tatiana Beresneva; Cynthia Helsabeck; Montessa Rodriguez; David L Bartlett; Steven K Libutti; James F Pingpank; H Richard Alexander
Journal:  J Gastrointest Surg       Date:  2004-02       Impact factor: 3.452

7.  Colorectal liver metastases.

Authors:  Ashraf J Haddad; Murad Bani Hani; Timothy M Pawlik; Steven C Cunningham
Journal:  Int J Surg Oncol       Date:  2011-06-06

8.  Evaluation of Delcath Systems' Generation 2 (GEN 2) melphalan hemofiltration system in a porcine model of percutaneous hepatic perfusion.

Authors:  Fred M Moeslein; Elizabeth G McAndrew; William M Appling; Nicole E Hryniewich; Kevin D Jarvis; Steven M Markos; Timothy P Sheets; Rajneesh P Uzgare; Daniel S Johnston
Journal:  Cardiovasc Intervent Radiol       Date:  2014-01-09       Impact factor: 2.740

Review 9.  Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.

Authors:  Mark C Burgmans; Eleonora M de Leede; Christian H Martini; Ellen Kapiteijn; Alexander L Vahrmeijer; Arian R van Erkel
Journal:  Cardiovasc Intervent Radiol       Date:  2015-12-30       Impact factor: 2.740

10.  Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.

Authors:  T Susanna Meijer; Jan H N Dieters; Eleonora M de Leede; Lioe-Fee de Geus-Oei; Jaap Vuijk; Christian H Martini; Arian R van Erkel; Jacob Lutjeboer; Rutger W van der Meer; Fred G J Tijl; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.